Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caris Life Sciences (CAI) Operating Income (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Operating Income data on record, last reported at $32.6 million in Q3 2025.

  • For Q3 2025, Operating Income fell 12.29% year-over-year to $32.6 million; the TTM value through Sep 2025 reached $14.8 million, changed N/A, while the annual FY2025 figure was $45.1 million, 117.55% up from the prior year.
  • Operating Income reached $32.6 million in Q3 2025 per CAI's latest filing, up from -$18.0 million in the prior quarter.
  • Across five years, Operating Income topped out at $37.2 million in Q3 2024 and bottomed at -$67.0 million in Q2 2024.